Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Model Ensembling and Machine Learning Approaches to Predict the First Dose of Amoxicillin in Intensive Care.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy.

Antimicrobial agents and chemotherapy·2026
Same author

Preemptive Pharmacogenetics in Renal Transplantation: A Real-World Assessment of Pharmacogenetic Actionability.

Therapeutic drug monitoring·2026
Same author

Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing.

The Journal of antimicrobial chemotherapy·2026
Same author

Raltegravir Plasma Exposure: A Machine Learning-Based Model for its Prediction Using Limited Sampling Strategy.

The AAPS journal·2026
Same author

Challenges in early detection and prognostication of sepsis: new approaches from the emergency department and intensive care unit.

EClinicalMedicine·2026

相关实验视频

Updated: Jun 13, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

在功能缺陷中使用模型信息精确剂量优化daptomycin剂量优化.

Hamza Sayadi1, Yeleen Fromage1, Marc Labriffe1,2

  • 1Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.

Therapeutic drug monitoring
|September 12, 2024
PubMed
概括

该案例研究强调了优化严重功能障碍患者的达普托米辛剂量,以避免毒性并确保对MRSA感染的治疗疗效. 根据治疗药物监测调整剂量至关重要.

更多相关视频

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

521
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.5K

相关实验视频

Last Updated: Jun 13, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

521
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.5K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 传染性疾病 传染性疾病

背景情况:

  • 达普托米辛暴露会影响疗效和毒性,个体变化很大.
  • 一名患有严重功能障碍 (eGFR 12 mL/min/1.73 m2) 的患者接受了针对MRSA感染性内心炎的达普托米辛治疗.
  • 标准剂量指南缺乏对EGFR<30mL/min/1.73m2的患者的达普托米辛的明确建议.

研究的目的:

  • 在患有严重功能障碍的患者中优化达普托米辛剂量.
  • 确保治疗药物暴露,同时尽量减少毒性风险.
  • 在功能障碍患者中有效管理MRSA传染性内心炎.

主要方法:

  • 用一个人群的药理动力学模型来估计贝叶斯参数.
  • 使用高峰和低谷血样本计算曲线下的24小时面积 (AUC24).
  • 根据AUC24/MIC比率和毒性值进行代调整的达普托米辛剂量.

主要成果:

  • 最初的达普素AUC24为1091小时·毫克/升,超过了毒性目标范围.
  • 将剂量减少到700毫克,然后每隔一天减少500毫克.
  • 最后调整剂量达到750h·mg/L的AUC24,在所需的治疗范围内.

结论:

  • 通过调整达普托米辛剂量,成功治疗MRSA感染性内心炎.
  • 该案强调了治疗药物监测在功能障碍患者的重要性.
  • 多学科的方法对于个性化达普胺剂量调整至关重要.